NCT02261805 2018-04-23A Phase I/II Study of Ganetespib in Combination With DoxorubicinGeorgetown UniversityPhase 1/2 Terminated11 enrolled 7 charts
NCT02192541 2018-03-29Ganetespib and Ziv-Aflibercept in Refractory Gastrointestinal Carcinomas, Non-Squamous Non-Small Cell Lung Carcinomas, Urothelial Carcinomas, and SarcomasNational Institutes of Health Clinical Center (CC)Phase 1 Terminated5 enrolled 15 charts